Invenomic Capital Management’s Concentrix CNXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.3M | Buy |
686,916
+152,652
| +29% | +$8.07M | 2.06% | 7 |
|
|
2025
Q1 | $29.7M | Sell |
534,264
-132,169
| -20% | -$7.35M | 1.5% | 16 |
|
|
2024
Q4 | $28.8M | Buy |
666,433
+194,190
| +41% | +$8.4M | 1.37% | 12 |
|
|
2024
Q3 | $24.2M | Buy |
472,243
+368,295
| +354% | +$18.9M | 1.33% | 23 |
|
|
2024
Q2 | $6.58M | Buy |
+103,948
| New | +$6.58M | 0.32% | 90 |
|
|
2023
Q4 | – | Sell |
-53,528
| Closed | -$4.29M | – | 175 |
|
|
2023
Q3 | $4.29M | Buy |
53,528
+29,745
| +125% | +$2.38M | 0.18% | 102 |
|
|
2023
Q2 | $1.92M | Buy |
+23,783
| New | +$1.92M | 0.1% | 116 |
|